GSK plc
GSK plc (GSK) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GSK · as of Jun 8, 2026
Key Statistics
Explore GSK plc Data
gsk stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 29 · Buy rate: 31.0%
The GSK analyst consensus is Hold, based on ratings from 29 Wall Street analysts over the past 3 months. The average 12-month price target is $52.45, representing +1.81% upside from the current price of $51.52.
Competitors & Peers
gsk competitorsGSK
BMY
CELG-RI
CI
CVS
ELVStock Performance
Full HistoryAbout GSK plc
GSK plc together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the …
what is gsk plc · gsk stock overview · gsk plc company profile · who is gsk plc ceo · gsk NYSE · gsk plc headquarters · gsk plc business segments
About Stock Overview & Key Data
GSK plc (GSK) is a Healthcare company in the Drug Manufacturers - General industry, listed on NYSE since Mar 28, 1980. As of the latest trading session, GSK stock price is $51.52, with a market capitalization of $103.6B. The stock has returned +26.09% over the past 12 months and +5.06% year-to-date.
According to 29 Wall Street analysts, the consensus rating for GSK plc stock is Hold, with an average 12-month price target of $52.45. In fiscal year 2025, GSK plc reported revenue of $32.7B and net income of $5.7B. For detailed data — including GSK plc revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, GSK plc (GSK) stock price is $51.52. The stock is traded on NYSE under the ticker symbol GSK. The 52-week range is $35.45 – $61.70.